Company / Assets per Share
Jazz Pharmaceuticals Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$192.30
FY2025
5-year range
$175.80 / $218.95
FY2021-FY2025
Trend
-0.3%
vs FY2024
Sector context
#5 of 210
Health Care
What the data says
Among 210 Health Care companies, Jazz Pharmaceuticals is in the top 2% for assets per share. Assets per Share has fluctuated over the past 10 years, ranging from $78.30 in FY2016 to $218.95 in FY2021.
Based on SEC 10-K filings.
192.30 in FY2025 with a 5-year CAGR of +10.6%. Top quartile in the Health Care sector.
Improved from $180.23 to $192.30 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 210This company $192.30 Sector average $296.79
▼
-35.2% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 0.3% year-over-year.
- Ranks #5 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $192.30 | -0.3% |
| FY2024 | $192.95 | +7.1% |
| FY2023 | $180.23 | +2.5% |
| FY2022 | $175.80 | -19.7% |
| FY2021 | $218.95 | +88.1% |
| FY2020 | $116.42 | +21.3% |
| FY2019 | $95.99 | +8.6% |
| FY2018 | $88.35 | +3.1% |
| FY2017 | $85.65 | +9.4% |
| FY2016 | $78.30 | +42.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026